Voloridge Investment Management’s Thermo Fisher Scientific TMO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | – | Sell |
-300,111
| Closed | -$122M | – | 1388 |
|
|
2025
Q2 | $122M | Buy |
300,111
+292,743
| +3,973% | +$122M | 0.45% | 38 |
|
|
2025
Q1 | $3.67M | Sell |
7,368
-6,993
| -49% | -$3.79M | 0.01% | 857 |
|
|
2024
Q4 | $7.47M | Buy |
+14,361
| New | +$7.9M | 0.03% | 661 |
|
|
2023
Q4 | – | Sell |
-3,680
| Closed | -$1.86M | – | 1477 |
|
|
2023
Q3 | $1.86M | Sell |
3,680
-24,171
| -87% | -$12.9M | 0.01% | 941 |
|
|
2023
Q2 | $14.5M | Buy |
+27,851
| New | +$15M | 0.07% | 372 |
|
|
2022
Q4 | – | Sell |
-2,765
| Closed | -$1.4M | – | 1639 |
|
|
2022
Q3 | $1.4M | Buy |
+2,765
| New | +$1.55M | 0.01% | 1081 |
|
|
2021
Q4 | – | Sell |
-15,356
| Closed | -$8.77M | – | 1845 |
|
|
2021
Q3 | $8.77M | Sell |
15,356
-197,592
| -93% | -$108M | 0.06% | 474 |
|
|
2021
Q2 | $107M | Sell |
212,948
-86,576
| -29% | -$40.8M | 0.74% | 7 |
|
|
2021
Q1 | $137M | Buy |
299,524
+241,002
| +412% | +$115M | 1% | 8 |
|
|
2020
Q4 | $27.3M | Buy |
58,522
+35,406
| +153% | +$16.6M | 0.23% | 106 |
|
|
2020
Q3 | $10.2M | Buy |
+23,116
| New | +$9.55M | 0.08% | 259 |
|
|
2020
Q2 | – | Sell |
-37,017
| Closed | -$10.5M | – | 1495 |
|
|
2020
Q1 | $10.5M | Buy |
37,017
+13,845
| +60% | +$4.37M | 0.3% | 70 |
|
|
2019
Q4 | $7.53M | Buy |
+23,172
| New | +$7.03M | 0.15% | 177 |
|
|
2019
Q3 | – | Sell |
-20,529
| Closed | -$6.03M | – | 1222 |
|
|
2019
Q2 | $6.03M | Buy |
+20,529
| New | +$5.65M | 0.17% | 123 |
|
|
2018
Q2 | – | Sell |
-31,156
| Closed | -$6.43M | – | 605 |
|
|
2018
Q1 | $6.43M | Buy |
+31,156
| New | +$6.54M | 0.15% | 123 |
|
|
2017
Q4 | – | Sell |
-20,788
| Closed | -$3.93M | – | 606 |
|
|
2017
Q3 | $3.93M | Buy |
+20,788
| New | +$3.76M | 0.09% | 214 |
|
|
2017
Q1 | – | Sell |
-43,662
| Closed | -$6.16M | – | 688 |
|
|
2016
Q4 | $6.16M | Sell |
43,662
-3,523
| -7% | -$519K | 0.13% | 198 |
|
|
2016
Q3 | $7.5M | Buy |
+47,185
| New | +$7.27M | 0.16% | 87 |
|
|
2016
Q2 | – | Sell |
-51,383
| Closed | -$7.28M | – | 398 |
|
|
2016
Q1 | $7.28M | Buy |
+51,383
| New | +$6.89M | 0.17% | 121 |
|
|
2015
Q3 | – | Sell |
-24,751
| Closed | -$3.21M | – | 393 |
|
|
2015
Q2 | $3.21M | Buy |
+24,751
| New | +$3.23M | 0.16% | 137 |
|
|
2015
Q1 | – | Sell |
-9,524
| Closed | -$1.19M | – | 327 |
|
|
2014
Q4 | $1.19M | Buy |
+9,524
| New | +$1.16M | 0.07% | 135 |
|
Other funds holding TMO
Voloridge Investment Management's TMO Position: Q3 2025 in Review
Voloridge Investment Management sold out of Thermo Fisher Scientific (TMO) in Q3 2025, closing a stake of 300,111 shares — an estimated $122M sold.
Voloridge Investment Management first reported a position in TMO in Q4 2014 and held it in 21 quarters. The position peaked at $137M in Q1 2021. 2,508 funds tracked by Wall St. Rank hold TMO as of Q3 2025.
- Voloridge Investment Management reported no remaining Thermo Fisher Scientific position as of Q3 2025 after selling out during the quarter.
- Voloridge Investment Management sold 300,111 Thermo Fisher Scientific shares in Q3 2025, an estimated $122M.
- Voloridge Investment Management first reported a position in Thermo Fisher Scientific in Q4 2014 and held it in 21 quarters.
- Voloridge Investment Management's Thermo Fisher Scientific position peaked at $137M in Q1 2021.
- 2,508 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q3 2025.
Based on Voloridge Investment Management's 13F filing for Q3 2025, filed 14 Nov 2025.